BLOCK OF HEPATITIS DELTA INFECTION BY THE ENTRY INHIBITOR MYRCLUDEX B IN UPA MICE: ESTABLISHMENT OF AN EFFICIENT MOUSE MODEL FOR HUMAN HBV/HDV INFECTION

被引：0

作者：

Lutgehetmann, M. ^{[1
,2
]}

Mancke, L. V. ^{[1
]}

Allweiss, L. ^{[1
]}

Volz, T. ^{[1
]}

Helbig, M. ^{[1
]}

Lohse, A. W. ^{[1
]}

Alexandrov, A. ^{[3
]}

Petersen, J. ^{[4
]}

Urban, S. ^{[5
]}

Dandri, M. ^{[1
]}

机构：

[1] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med, Hamburg, Germany

[2] Univ Med Ctr Hamburg Eppendorf, Dept Med Microbiol Virol & Hyg, Hamburg, Germany

[3] Vis 7 GMBH, Frankfurt, Germany

[4] Asklepios Clin St Georg, Inst Interdisciplinary Med, Hamburg, Germany

[5] Univ Heidelberg Hosp, Dept Infect Dis, Heidelberg, Germany

来源：

JOURNAL OF HEPATOLOGY | 2011年 / 54卷

关键词：

D O I：

10.1016/S0168-8278(11)60107-4

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

105

引用

页码：S47 / S47

页数：1

共 50 条

[1] MYRClUDEX-B Viral entry inhibitor Treatment of hepatitis B virus (HBV) and HDV infection
Cole, P.
DRUGS OF THE FUTURE, 2015, 40 (07) : 433 - 436
[2] ADMINISTRATION OF THE ENTRY INHIBITOR MYRCLUDEX-B AFTER ESTABLISHMENT OF HEPATITIS B VIRUS INFECTION PREVENTS VIRAL SPREADING AMONG HUMAN HEPATOCYTES IN UPA MICE
Ben M'Barek, M.
Volz, T.
Lutgehetmann, M.
Bornscheuer, T.
Allweiss, L.
Lohse, A. W.
Alexandrov, A.
Urban, S.
Petersen, J.
Dandri, M.
JOURNAL OF HEPATOLOGY, 2011, 54 : S33 - S33
[3] MYRCLUDEX-B INHIBITS ESTABLISHMENT OF HDV SUPER-INFECTION IN HBV INFECTED MICE AND REDUCES HDV VIREMIA IN STABLY HBV/HDV CO-INFECTED MICE
Volz, T.
Giersch, K.
Allweiss, L.
Bhadra, O. D.
Petersen, J.
Lohse, A. W.
Luetgehetmann, M.
Urban, S.
Dandri, M.
JOURNAL OF HEPATOLOGY, 2015, 62 : S514 - S514
[4] PRECLINICAL STUDIES ON MYRCLUDEX B, A NOVEL ENTRY INHIBITOR FOR HEPATITS B- AND HEPATITIS DELTA VIRUS (HDV) INFECTIONS
Urban, S.
Schulze, A.
Schieck, A.
Gaehler, C.
Ni, Y.
Meier, A.
Alexandrov, A.
Mier, W.
JOURNAL OF HEPATOLOGY, 2010, 52 : S5 - S5
[5] Study of the super-infection by Hepatitis B Virus (HBV) and Hepatitis Delta Virus (HDV) in the HepaRG cell model
Alfaiate, D.
Abeyrickrama-Samarakoon, N.
Testoni, B.
Lucifora, J.
Zoulim, F.
Cortay, J-C
Deny, P.
Durantel, D.
JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 7 - 8
[6] Quantification of serum markers of hepatitis B (HBV) and Delta virus (HDV) infections in patients with chronic HDV infection
Ricco, G.
Popa, D. C.
Cavallone, D.
Iacob, S.
Salvati, A.
Tabacelia, D.
Oliveri, F.
Mascolo, G.
Bonino, F.
Yuan, Q.
Xia, N. -S
Gheorghe, L.
Brunetto, M. R.
JOURNAL OF VIRAL HEPATITIS, 2018, 25 (08) : 911 - 919
[7] LYMPHOKINE PATTERN IN CHRONIC HEPATITIS-B VIRUS (HBV) AND HEPATITIS DELTA VIRUS (HDV) INFECTION
MAGRIN, S
CRAXI, A
CARINI, C
MESSINA, MC
ANTONELLI, G
AUSIELLO, C
SPAGNOLI, G
DIANZANI, F
PAGLIARO, L
PATHOPHYSIOLOGY OF THE LIVER, 1988, 786 : 99 - 107
[8] Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
Sheldon, Julie
Ramos, Belen
Toro, Carlos
Rios, Pilar
Martinezz-Alarcon, Jose
Bottecchia, Marcelle
Romero, Miriam
Garcia-Samamiego, Javier
Soriano, Vincent
ANTIVIRAL THERAPY, 2008, 13 (01) : 97 - 102
[9] Pretreatment of humanized upa/scid mice with interferon alpha inhibits the establishment of Hepatitis B virus infection but not hepatitis d virus entry
Luetgehetmann, Marc
Braunschmidt, Jan-Lukas
Volz, Tassilo
Allweiss, Lena
Giersch, Katja
Lohse, Ansgar W.
Petersen, Joerg
Dandri, Maura
HEPATOLOGY, 2012, 56 : 423A - 423A
[10] THE ENTRY INHIBITOR MYRCLUDEX-B EFFICIENTLY BLOCKS VIRAL SPREADING IN VIVO IN HUMAN LIVER CHIMERIC UPA/SCID MICE PREVIOUSLY INFECTED WITH HEPATITIS B VIRUS
Lutgehetmann, Marc
Petersen, Joerg
Volz, Tassilo
Allweiss, Lena
Lohse, Ansgar W.
Urban, Stephan
Dandri, Maura
HEPATOLOGY, 2011, 54 : 372A - 372A

← 1 2 3 4 5 →